| 查看: 626 | 回复: 2 | |||
1949stone荣誉版主 (知名作家)
海纳百川
|
[交流]
Phylogeny programs 已有2人参与
|
|
http://evolution.genetics.washington.edu/phylip/software.html Here are 392 phylogeny packages and 54 free web servers, (almost) all that I know about. It is an attempt to be completely comprehensive. I have not made any attempt to exclude programs that do not meet some standard of quality or importance. Updates to these pages are made roughly monthly. Here is a "waiting list" of new programs waiting to have their full entries constructed. Many of the programs in these pages are available on the web, and some of the older ones are also available from ftp server machines. The programs listed below include both free and non-free ones; in some cases I do not know whether a program is free. I have listed as free those that I knew were free; for the others you have to ask their distributor. Usually when I say that a program is downloadable from a web site, this means that it is available free. Email addresses in these pages have had the @ symbol replaced by (at) and also surrounded by invisible confusing tags and blank characters in hopes of foiling spambots that harvest email addresses. If you discover any inaccuracies, or feel that I have left any important programs or facts out, or if links do not work properly, please e-mail me at: (joe (at) gs.washington.edu). You can also use the submission form here to submit new entries. |
» 猜你喜欢
卟啉家族中的明星分子:MESO-四(3,5-二溴-4-羟基苯基)卟啉的性质与制备
已经有1人回复
宠物寄生虫防治:氟雷拉纳阻断GABA受体,持效12周驱杀跳蚤蜱虫
已经有0人回复
化学工程及工业化学论文润色/翻译怎么收费?
已经有95人回复
为呼吸打开通道:依伐卡托的科学之旅
已经有1人回复
Dordaviprone(ONC201):小分子药物在中线胶质瘤中的应用
已经有0人回复
依喜替康:新型喜树碱衍生物的研究进展
已经有1人回复
膀胱癌靶向治疗新选择:厄达替尼作用机制与耐药研究进展
已经有0人回复
从水母到实验室:腔肠素的发现历程与生物发光奥秘
已经有1人回复
线粒体氧化磷酸化的新靶点:S-Gboxin的发现与研究进展
已经有0人回复
PROTAC药物开发选择VHL配体:MDK-7526以87%出口向量占有率成首选
已经有0人回复
MCC950:NLRP3炎症小体特异性抑制剂的科研应用与前景
已经有0人回复
» 本主题相关价值贴推荐,对您同样有帮助:

lvbobo823
铁杆木虫 (正式写手)
- 应助: 363 (硕士)
- 金币: 7753.3
- 散金: 15
- 红花: 9
- 帖子: 751
- 在线: 189.4小时
- 虫号: 819723
- 注册: 2009-07-31
- 性别: GG
- 专业: 植物遗传学

2楼2014-01-08 20:45:45
![]() |
3楼2014-01-10 15:53:44












回复此楼